Global Medical Directory is part of the Informa Markets Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Ebola Ag – RapiGEN
Connect with this vendor - Learn about this product

Ebola Ag

The Ebola virus causes an acute, serious illness which is often fatal if untreated. Ebola virus disease (EVD) first appeared in 1976 in 2 simultaneous outbreaks, one in Nzara, Sudan, and the other in Yambuku, Democratic Republic of Congo. The latter occurred in a village near the Ebola River, from which the disease takes its name. Ebola is introduced into the human population through close contact with the blood, secretions, organs or other bodily fluids of infected animals. Ebola virus then spreads through person-to-person transmission via contact with the blood, secretions, organs or other bodily fluids of infected people, and indirect contact with environments contaminated with such fluid, including in healthcare settings. The onset of symptoms is sudden and includes fever, muscle aches, weakness, headache and sore throat. The next stage is characterized by vomiting, diarrhea, rash and malfunction of liver and kidneys. Normal incubation period of the Ebola disease is 2 to 21 days from the contact of virus. If not treated properly, Ebola disease can be fatal. Early detection is the key in fighting Ebola virus.